DEB-BACE is a novel therapy for advanced lung cancer, and many studies have reported the efficacy of DEB-BACE for untreated NSCLC (Liu J et al., 2021; Liu XF et al., 2021). This evidence concerns the gene BACE1 and non-small cell lung carcinoma.